Survival from breast, colon, lung, ovarian and rectal cancer by geographical remoteness in New South Wales, Australia, 2000-2008.

OBJECTIVE This study aims to compare survival from breast, colon, lung, ovarian and rectal cancer by geographical remoteness in New South Wales (NSW). DESIGN Retrospective population-wide registry study. SETTING NSW, Australia. PARTICIPANTS A total of 107 060 NSW residents, who were diagnosed with any of the five cancers between 01 January 2000 and 31 December 2008. MAIN OUTCOME MEASURES Kaplan-Meier survival curves and proportional hazards regression were used to compare survival by geographical remoteness of residence at diagnosis, controlling for gender, age and extent of disease at diagnosis. Remoteness was classified using standard definitions: major city, inner regional (InnReg), outer regional (OutReg) and remote (including very remote). RESULTS Significant differences in survival (likelihood of death) were identified in all five cancers: breast (adjusted hazard ratio(HR) = 1.22 (95% confidence interval (CI), 1.001-1.48) in regionalised and HR = 1.30 (1.02-1.64) in metastatic disease for OutReg areas); colon (HR = 1.14 (1.01-1.29) for OutReg areas in metastatic disease); lung (HR range = 1.08-1.35 (1.01-1.48) for most non-metropolitan areas in all stages of disease excepting regionalised); ovarian (HR = 1.32 (1.06-1.65) for OutReg areas in metastatic disease, HR = 1.40 (1.04-1.90) for InnReg areas and HR = 1.68 (1.02-2.77) for OutReg areas in unknown stage of disease) and rectal (HR = 1.37 (1.05-1.78) for OutReg areas in localised and HR = 1.14 (1.002-1.30) for InnReg areas in regionalised disease). Where significant differences were found, major cities tended to show the best survival, whereas OutReg areas tended to show the worst. Although no definitive interpretation could be made regarding remote areas due to small patient numbers, their survival appeared relatively favourable. CONCLUSIONS Reasons that contribute to the differences observed and the disparate results between cancer types need to be further explored in order to facilitate targeted solutions in reducing survival inequality between NSW regions.

[1]  David P. Smith,et al.  Geographic variation in prostate cancer survival in New South Wales. , 2015, The Medical journal of Australia.

[2]  P. Satasivam,et al.  The dilemma of distance: patients with kidney cancer from regional Australia present at a more advanced stage , 2014, BJU international.

[3]  M. Coory,et al.  Australia is continuing to make progress against cancer, but the regional and remote disadvantage remains. , 2013, Medical Journal of Australia.

[4]  K. Mengersen,et al.  Spatial inequalities in colorectal and breast cancer survival: premature deaths and associated factors. , 2012, Health & place.

[5]  H. Gogas,et al.  Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study , 2012, European Journal of Epidemiology.

[6]  E. Tracey,et al.  What factors affect the odds of NSW cancer patients presenting with localised as opposed to more advanced cancer? , 2012, Cancer Causes & Control.

[7]  M. Coory Distance to the closest radiotherapy facility and survival after a diagnosis of rectal cancer in Queensland , 2011, The Medical journal of Australia.

[8]  Gavin Turrell,et al.  Geographic remoteness, area-level socio-economic disadvantage and advanced breast cancer: a cross-sectional, multilevel study , 2011, Journal of Epidemiology & Community Health.

[9]  R. Gibberd,et al.  A population-based study from New South Wales, Australia 1996-2001: area variation in survival from colorectal cancer. , 2005, European journal of cancer.

[10]  Gopal K Singh,et al.  Sociodemographic variations in breast cancer screening behavior among Australian women: results from the 1995 National Health Survey. , 2002, Preventive medicine.

[11]  Aged Care,et al.  Measuring Remoteness: Accessibility/Remoteness Index of Australia (ARIA) Revised Edition. Occasional Papers: New Series Number 14 , 2001 .